BDBM149410 US10434101, Compound I-10::US11096942, Compound I-10::US8975249, I-10

SMILES COc1cc(ccc1Nc1ncc(c(Oc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F)N1CCN(CC1)C(C)=O

InChI Key InChIKey=BKGAQRNSVMXWHB-UHFFFAOYSA-N

Data  12 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 149410   

TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  5.5nMpH: 7.5Assay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and ap...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  5.5nMpH: 7.5Assay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and ap...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  200nMAssay Description:Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Fudan University

Curated by ChEMBL
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  7.10nMAssay Description:Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  5.5nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  5.5nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  67nMAssay Description:Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  1.03E+3nMAssay Description:Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  7nMAssay Description:Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression syst...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  132nMAssay Description:Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  5.5nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM149410(US10434101, Compound I-10 | US11096942, Compound I...)
Affinity DataIC50:  5.5nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
In DepthDetails US Patent